Pharma Rep Focus

Gilead plots long-term cell therapy growth, maintains confidence in Trodelvy despite trial miss

Fierce Pharma

FEBRUARY 7, 2024

Despite markedly slower cell therapy growth from the third to the fourth quarter of 2023—and a recent setback for Trodelvy—historically HIV-focused Gilead Sciences is not discouraged amid its | Despite a tame level of fourth-quarter growth, recent advances should drive long-term cell therapy sustainability, Gilead execs said.

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Fierce Pharma

MAY 10, 2023

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal fkansteiner Wed, 05/10/2023 - 08:39

Manufacturing

Apellis parries Astellas' long-term Izervay data with 3-year results on its rival GA med Syfovre

Fierce Pharma

NOVEMBER 6, 2023

Now, Apellis Pharmaceuticals is putting up long-term data on Syfovre in a bid to outdo its new rival. After this summer’s FDA approval of Iveric Bio’s Izervay—the drug at the center of the $5.9 billion buyout by Japanese pharma Astellas—the battle for the geographic atrophy crown is on in the U.S.

Pharma

Pharma FDA Pharmaceutical

Bristol Myers Squibb leans on long-term growth drivers, strategy overhaul to dodge IRA impacts

Fierce Pharma

APRIL 25, 2024

Facing pressure from the Inflation Reduction Act (IRA) and falling sales for CAR-T therapy Abecma, Bristol Myers Squibb CEO Chris Boerner, Ph.D.,

Sales

The Modern Customer Success Playbook

Advertiser: ZoomInfo

Quarterbacking your customers to long-term success and growth is proven to combat churn and transform customer success teams into revenue-drivers. Satisfaction won’t cut it. But where do you start?

A Person-Centered Approach to Achieving Long-Term Success

Fierce Pharma

FEBRUARY 20, 2024

This week on “The Top Line,” we’re speaking with Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, Gilead Sciences about how advancements in HIV treatment research have enabled indiv | This week, we’re speaking with Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, Gilead Sciences about how advancements in HIV treatment (..)

Leads

Leads Medical

Short-Term Thinking Is Undermining Healthcare — Here’s What We Need Instead

MedCity News

FEBRUARY 29, 2024

Adopting an infinite mindset could be the antidote to the slow destruction of healthcare by short-term thinking.

Healthcare

Healthcare Healthcare

Long-term data indicates “significant” potential of aGvHD microbiome treatment

European Pharmaceutical Review

APRIL 15, 2024

Based on the long-term survival data, at 18 months MaaT013 enabled 42 percent overall survival in all patients and 58 percent in responder patients. MaaT013 shows remarkable efficacy at 18 months, yielding more complete responses in aGvHD patients who have shown resistance to current treatments, as compared to other available therapies.

Pharma

Pharma Patients Management Leads

Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak'

Fierce Pharma

FEBRUARY 13, 2024

While Biogen’s financials are in rough shape now, the company’s CEO, Chris Viebacher, sees reason to be optimistic about the future.

How ZoomInfo Enhances Your Database Management Strategy

Advertiser: ZoomInfo

It's quite a process for marketing teams to develop a long-term data management strategy. It involves finding a data management provider that can append contacts with correct information — in real-time. Not just that, but also ongoing data hygiene efforts to keep the incoming (and existing) information fresh.

Management

J&J reveal long-term data for novel oral peptide

European Pharmaceutical Review

MARCH 13, 2024

In the long-term extension FRONTIER 2 study , JNJ-2113 demonstrated sustained efficacy from Week 16 to Week 52, based on data presented at the American Academy of Dermatology (AAD) 2024 Annual Meeting. The post J&J reveal long-term data for novel oral peptide appeared first on European Pharmaceutical Review.

Safety

Safety Patients Pharmaceutical

EMA pins lack of long-term data as rationale for Novartis’ failed Vijoice bid

Pharmaceutical Technology

MARCH 14, 2024

The EMA raised concerns about the lack of long-term data for Novartis Vijoice in its initial bid, as the Swiss company prepares for a new regulatory submission.

Ferring reveals long-term data for cancer gene therapy

European Pharmaceutical Review

NOVEMBER 29, 2023

Following the US Food and Drug Administration (FDA)’s approval of Ferring Pharmaceuticals’ gene therapy Adstiladrin ® (nadofaragene firadenovec-vncg) in December 2022, new long-term follow up data has been revealed. The post Ferring reveals long-term data for cancer gene therapy appeared first on European Pharmaceutical Review.

Food and Drug Administration

Food and Drug Administration FDA Pharmaceutical Food

74% of Medicare Beneficiaries Concerned About Medicare’s Long-term Sustainability

MedCity News

AUGUST 13, 2023

About 20% of Medicare beneficiaries are “very worried” about the long-term sustainability of Medicare, 54% are “somewhat worried” and 25% are “not at all worried,” according to an eHealth survey.

Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial

Pharmaceutical Technology

APRIL 17, 2024

Discover Eagle Pharmaceuticals Inc's patented stable bendamustine-containing composition for long-term storage. Learn about the sterile vial with antioxidants ensuring impurities less than 5% after 15 months.

Pharmaceutical

ASH: AZ’s danicopan shows long-term benefit in PNH

pharmaphorum

DECEMBER 11, 2023

ASH: AZ’s danicopan shows long-term benefit in PNH Phil.Taylor Mon, 11/12/2023 - 12:08 Bookmark this

Apellis cites current challenges with Syfovre launch but bright prospects in the long term

Fierce Pharma

FEBRUARY 28, 2024

The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a roller-coaster ride. And there’s still more loops to negotiate. | The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a rollercoaster ride. And there are still more loops to negotiate.

Prospecting

Prospecting Marketing

Leveraging technology to meet HCPs and patients on their own terms

Fierce Pharma

NOVEMBER 11, 2022

Leveraging technology to meet HCPs and patients on their own terms. Fri, 11/11/2022 - 14:45.

Patients

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO

Fierce Pharma

MARCH 21, 2023

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO fkansteiner Tue, 03/21/2023 - 09:41

Prospecting

SHL, after bagging long-term contracts, lands financial support for drug delivery growth strategy

Fierce Pharma

DECEMBER 13, 2022

SHL, after bagging long-term contracts, lands financial support for drug delivery growth strategy. Tue, 12/13/2022 - 06:02.

Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says

Fierce Pharma

FEBRUARY 2, 2023

Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says kdunleavy Thu, 02/02/2023 - 10:43

AHA: High-deductible, Short-term Health Plans To Blame for Medical Debt

MedCity News

MARCH 23, 2023

The American Hospital Association said short-term limited duration health plans and high-deductible health plans are to blame. Of the more than 15% of American adults who have past-due medical debt, about 73% owe some or all of the money to hospitals, according to a recent Urban Institute report.

Medical

Buoyed by GLP-1 stars, Novo's sales soar in Q3. Will manufacturing prove a long-term hurdle?

Fierce Pharma

NOVEMBER 2, 2023

Ever since Novo Nordisk won FDA approval for its GLP-1 weight-loss med Wegovy more than 2 years ago, analysts and investors have been keeping a close eye on the blockbuster drug launch.

Manufacturing

Manufacturing FDA Sales

Some Additional Wrinkles to US Copyright Terms

Copyright Clearance Center

MARCH 22, 2023

The post Some Additional Wrinkles to US Copyright Terms appeared first on Copyright Clearance Center.

'We can't forget about this': As chemotherapy shortage ebbs and flows, attention shifts to long-term solutions

Fierce Pharma

SEPTEMBER 27, 2023

It’s been about 10 months since FDA inspectors rebuked a | As some cancer centers struggle to secure access to key platinum-based chemotherapies, a national spotlight gives the issue newfound political importance. But will this be a turning point for the recurrent shortage issue? ASCO's Julie Gralow, M.D., certainly hopes so.

FDA

siRNA therapy shows long-term potential in lowering LDL-C

European Pharmaceutical Review

AUGUST 28, 2023

Novartis has announced that Leqvio ® (inclisiran) , the first and only small interfering RNA (siRNA) therapy indicated to reduce low-density lipoprotein cholesterol (LDL-C), has demonstrated promising long-term results. The post siRNA therapy shows long-term potential in lowering LDL-C appeared first on European Pharmaceutical Review.

Food and Drug Administration

Food and Drug Administration Consulting Patients Food

GSK tamps down short-term expectations for RSV shot Arexvy, but still boosts 2023 guidance

Fierce Pharma

JULY 26, 2023

Expectations are sky high for GSK’s entry this fall into the new respiratory syncytial virus (RSV) vaccine market. | In a quarter fueled by sales of Shingrix and its HIV medicines, GSK topped revenue expectations and bumped up its sales projection for the year.

Sales

Sales Medicine Marketing

Long-term findings from CAR NK cell therapy trial revealed

European Pharmaceutical Review

JANUARY 18, 2024

The post Long-term findings from CAR NK cell therapy trial revealed appeared first on European Pharmaceutical Review. CAR NK cells have the potential to be manufactured in advance and stored for off-the-shelf immediate use,” Dr Rezvani commented.

Manufacturing

Manufacturing Patients Safety Medicine

BioSenic and Phebra switch up terms of licensing agreement

Pharmaceutical Technology

JANUARY 16, 2024

The updated binding term sheet for an oral arsenic trioxide therapy sees Phebra take on more duties and BioSenic given royalties.

Neoadjuvant nivolumab improves long-term survival for lung cancer

European Pharmaceutical Review

FEBRUARY 15, 2023

The results suggest “that neoadjuvant nivolumab was safe in long-term follow-up,” commented Patrick Forde, MBBCh, an Associate Professor of oncology and Director of the Thoracic Oncology Clinical Research Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Food and Drug Administration

Food and Drug Administration Patients Food Networking

Why Communicating Data Results is Critical to Long-Term BioPharma Success

MedCity News

FEBRUARY 15, 2024

Providing a clear and unwavering roadmap of anticipated milestones will ensure that no matter the inevitable bumps or detours, your stakeholders can always see the path forward and track your progress.

Biopharma

Report: More than 11M middle-income seniors won’t be able to afford long-term care by 2033

MedCity News

SEPTEMBER 11, 2022

The lead author called for efforts to be taken to improve the affordability of long-term care for seniors, particularly for those of lower income. Middle-income seniors are those who are unlikely to qualify for Medicaid but do not have adequate resources to pay for the housing and care options they need.

Leads

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

Management

Management Side effects Patients Safety

Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy

MedCity News

JANUARY 24, 2023

Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.

FDA

FDA Biopharma Pharma

CDMO: Indena’s Long-Term Vision

Pharmaceutical Technology

FEBRUARY 29, 2024

Indena CDMO origin: Founded in 1921 by Carlo Boccaccio Inverni and Biagio Alberto Della Beffa and headquartered in Milan, Indena…

A Model for Modern Pharmacy Billing and Payments in Long-Term Care Centers

Pharmacy Times

APRIL 26, 2024

Pharmacists working with long-term care centers benefit from streamlined billing to support and build patient trust.

Patients

Long Term Impact: How the Healthcare Industry Can Survive Staffing Shortages

MedCity News

NOVEMBER 29, 2023

By streamlining front-end processes, reducing errors, and ensuring prompt service delivery, AI and automation not only boost the patient experience but also optimize revenue streams.

Healthcare

Healthcare Healthcare Patients

Digital CBT reduced distress in patients with long-term physical health conditions

PharmaTimes

FEBRUARY 19, 2024

Participants who received COMPASS showed a clinically significant improvement after 12 weeks

Patients

AbbVie’s Skyrizi® shows long-term efficacy in psoriatic arthritis

European Pharmaceutical Review

SEPTEMBER 15, 2022

Long-term data from the KEEPsAKE trials shows more than half of adult psoriatic arthritis patients receiving Skyrizi ® (risankizumab, 150mg) achieving a 90 percent reduction in the Psoriasis Area and Severity Index (PASI 90) and an American College of Rheumatology 20 (ACR20) response at 100 weeks. events/100 patient-years (E/100PY) and 9.9

Safety

Safety Physicians Patients Consulting

It’s been a long time coming for long-term topical psoriasis treatments

pharmaphorum

OCTOBER 26, 2022

Unlike traditional topical steroids, Vtama and Zoryve are safe for long-term use. At a cheaper cost for health plans and patients alike, and with the ability to be used long term, nonsteroidal topicals like Vtama and Zoryve are a welcome addition to dermatologists’ arsenal. All that’s missing is a catchy theme song.

Side effects

Side effects Food and Drug Administration Patients Management

Coloplast Announces Agreement to Acquire Kerecis and Raises Long-term Growth Expectations

Legacy MEDSearch

JULY 7, 2023

In the following years, the EBIT margin is expected to be in line with Coloplast’s long-term guidance of more than 30% The acquisition is expected to accelerate Coloplast’s group organic growth with around 1%-point contribution as of FY 2024/25. from Kerecis (incl. billion (around DKK 8.9 billion), consisting of USD 1.2 billion (around DKK 8.2

Recruitment

Recruitment Management Medical Networking

Study: Pain After Heart Attack Linked With Long-Term Survival

Pharmacy Times

AUGUST 24, 2023

Notably, 65% of the participants experiencing pain at the 2-month follow up were also experiencing pain at their 12-month follow up, suggesting persistent and long-term pain.

Reconfiguring COVID and influenza vaccines for long-term effectiveness

pharmaphorum

SEPTEMBER 22, 2022

Le Vert says Osivax’s technology differs, however, as it attacks the virus’ T-cells, making the vaccine more effective in the long term, and that clinical trials have shown promise. The post Reconfiguring COVID and influenza vaccines for long-term effectiveness appeared first on.

Training

Training Specialization Recruitment Management

Healthcare’s Digitization: Coming to Terms with Cybersecurity Supply Chain Risk

MedCity News

JANUARY 5, 2023

Providers are, in many cases, getting the equivalent of a Russian nesting doll of third-party risks whenever they acquire a complex new technology solution.

Management

Gilead plots long-term cell therapy growth, maintains confidence in Trodelvy despite trial miss

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Trending Sources

Apellis parries Astellas' long-term Izervay data with 3-year results on its rival GA med Syfovre

Bristol Myers Squibb leans on long-term growth drivers, strategy overhaul to dodge IRA impacts

The Modern Customer Success Playbook

A Person-Centered Approach to Achieving Long-Term Success

Short-Term Thinking Is Undermining Healthcare — Here’s What We Need Instead

Long-term data indicates “significant” potential of aGvHD microbiome treatment

Biogen CEO plots long-term turnaround after analysts brand company's recent results as 'weak'

How ZoomInfo Enhances Your Database Management Strategy

J&J reveal long-term data for novel oral peptide

EMA pins lack of long-term data as rationale for Novartis’ failed Vijoice bid

Ferring reveals long-term data for cancer gene therapy

74% of Medicare Beneficiaries Concerned About Medicare’s Long-term Sustainability

Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial

ASH: AZ’s danicopan shows long-term benefit in PNH

Apellis cites current challenges with Syfovre launch but bright prospects in the long term

Leveraging technology to meet HCPs and patients on their own terms

Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO

SHL, after bagging long-term contracts, lands financial support for drug delivery growth strategy

Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says

AHA: High-deductible, Short-term Health Plans To Blame for Medical Debt

Buoyed by GLP-1 stars, Novo's sales soar in Q3. Will manufacturing prove a long-term hurdle?

Some Additional Wrinkles to US Copyright Terms

'We can't forget about this': As chemotherapy shortage ebbs and flows, attention shifts to long-term solutions

siRNA therapy shows long-term potential in lowering LDL-C

GSK tamps down short-term expectations for RSV shot Arexvy, but still boosts 2023 guidance

Long-term findings from CAR NK cell therapy trial revealed

BioSenic and Phebra switch up terms of licensing agreement

Neoadjuvant nivolumab improves long-term survival for lung cancer

Why Communicating Data Results is Critical to Long-Term BioPharma Success

Report: More than 11M middle-income seniors won’t be able to afford long-term care by 2033

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

Astellas Plots Near-Term Moves to Execute Long-Term Vision in Gene Therapy

CDMO: Indena’s Long-Term Vision

A Model for Modern Pharmacy Billing and Payments in Long-Term Care Centers

Long Term Impact: How the Healthcare Industry Can Survive Staffing Shortages

Digital CBT reduced distress in patients with long-term physical health conditions

AbbVie’s Skyrizi® shows long-term efficacy in psoriatic arthritis

It’s been a long time coming for long-term topical psoriasis treatments

Coloplast Announces Agreement to Acquire Kerecis and Raises Long-term Growth Expectations

Study: Pain After Heart Attack Linked With Long-Term Survival

Reconfiguring COVID and influenza vaccines for long-term effectiveness

Healthcare’s Digitization: Coming to Terms with Cybersecurity Supply Chain Risk

Stay Connected